|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09906 HONLIV HEALTH
Nominal 
1.500 0.000 (0.000%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 346,820 | -16.465% | 768,725 | 760,527 | 727,789 | 606,837 |
| Cost of Sales | (301,019) | -12.382% | (642,033) | (615,683) | (589,394) | (471,531) |
| Gross Profit | 45,801 | -36.051% | 126,692 | 144,844 | 138,395 | 135,306 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 209 | -- | (530) | (15,294) | (1,963) | (85) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (709) | -- | 42,698 | 51,422 | 63,021 | 50,542 | |
| Taxation | 33 | -- | (11,222) | (12,724) | (13,678) | (13,524) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 3 | -- | (325) | (388) | (396) | (403) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (673) | -- | 31,151 | 38,310 | 48,947 | 36,615 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 4,198 | 12.066% | 7,723 | 6,023 | (1,460) | 16,019 |
| Depreciation & Amortisation | -- | -- | 74,524 | 60,236 | 54,755 | 33,713 |
| Directors' Emoluments | -- | -- | 3,038 | 3,092 | 3,074 | 2,750 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -0.124 | -- | 6.000 | 7.000 | 8.000 | 6.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.152 | 0.157 | 0.200 | 0.152 |
| NBV per share ($) | 0.925 | -- | 0.955 | 0.903 | 0.916 | 0.936 |
| Remarks: | Real time quote last updated: 30/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -673 |
| %Change | -- |
| EPS / (LPS) | RMB -0.001 |
| NBV Per Share (¥) | RMB 0.925 |